(Q61979316)

English

Second-Line Irinotecan vs. ILF for AGC

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Randomized Phase II Trial of Irinotecan Monotherapy Versus Irinotecan, Leucovorin and 5-FU (ILF) Combination Chemotherapy in Patients With Advanced Gastric Cancer Failing Prior Chemotherapy (English)

0 references

sponsor

Gachon University Gil Medical Center

0 references

start time

May 2007

0 references

number of participants

50

0 references

research intervention

irinotecan

0 references

clinical trial phase

phase II clinical trial

0 references

research site

Gachon University Gil Medical Center

0 references

research subject recruitment status

unknown

0 references

minimum age

18 year

0 references

maximum age

75 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00509964

0 references

(Q61979316)

Second-Line Irinotecan vs. ILF for AGC

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)